Zuranolon (1) – Zurzuvae®
Postnatal depression
Characteristics
| Start date | 15.07.2026 |
|---|---|
| Resolution | 07.01.2027 – active procedure |
| INN | Zuranolon |
| Brand name | Zurzuvae® |
| Pharm. company | Biogen GmbH |
| G-BA Procedure ID | D-1341 |
| Therapeutic area | Mental illnesses |
| Reason for procedure | Initial assessment |
Associated procedures
<< List of all resolutions